Anthem (Elevance Health) Prior Authorization for Allergy & Immunology

Successfully navigating Anthem (Elevance Health) prior authorization for allergy & immunology services, including high-cost biologics and IVIG, requires precise understanding of payer-specific channels and clinical criteria.

Revenue cycle directors and prior authorization coordinators face unique challenges with Anthem's diverse medical and pharmacy benefit structures when managing allergy and immunology services. From asthma biologics to IVIG/SCIG and allergen immunotherapy, each category demands adherence to specific submission pathways and clinical guidelines to prevent delays and denials.

Key Prior Authorization Categories for Allergy & Immunology with Anthem

Anthem-licensed plans frequently flag high-cost and specialty allergy & immunology treatments for prior authorization. This includes critical categories such as biologics for asthma and other allergic conditions, intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) therapies, and certain allergen immunotherapy regimens. Understanding the specific clinical criteria for each is paramount.

Anthem Submission Channels for Allergy & Immunology PAs

Medical benefit prior authorizations for Anthem-licensed plans, including many allergy & immunology services, are primarily submitted via Availity Essentials, Anthem's multi-payer provider workspace. This platform facilitates PA initiation, benefit lookups, and document uploads. For pharmacy benefit PAs, CarelonRx (Anthem's in-house PBM) processes retail PA requests through its provider system, with additional support from CoverMyMeds and Surescripts ePA for prescriber-initiated workflows. X12 278 transactions are also accepted for impacted medical procedures.

Accessing Anthem's Medical Policies and Clinical Criteria

Anthem operating companies publish medical policies and clinical utilization management guidelines through provider sites accessible via Availity. Each state-licensed Anthem plan maintains its own medical-policy index, which aligns with the Elevance Health corporate criteria framework and includes state-specific Medicaid and Medicare Advantage variants. When preparing a prior authorization for allergy & immunology, always reference the specific policy number, plan-state context, and effective date. Criteria may be Anthem-developed, MCG-based, or NCCN-compendium-based for oncology, as disclosed in the policy.

Common Denial Patterns for Allergy & Immunology with Anthem

Prior authorization denials from Anthem-licensed plans for allergy & immunology services often stem from medical necessity disputes, insufficient documentation, or failure to complete required step therapy protocols (common for biologics). Site-of-service mismatch is another frequent denial pattern, particularly for infusions, given Anthem's active site-of-care policies. Additionally, denials can occur if a procedure is not covered under the specific state-plan benefit grid or due to non-formulary pharmacy denials for retail drugs. Denials are typically returned via X12 277/835 transactions and Availity status updates.

Electronic Prior Authorization (ePA) Posture

Elevance Health, through its Anthem operating companies, has actively participated in Da Vinci Project initiatives and HL7 connectathons, signaling a commitment to electronic prior authorization (ePA) standards like Da Vinci PAS. While specific production conformance requires verification of current public disclosures, the acceptance of X12 278 transactions is established. For pharmacy benefits, CoverMyMeds and Surescripts ePA provide electronic submission pathways for retail pharmacy PAs through CarelonRx.

Turnaround Times and Appeals for Allergy & Immunology PAs

Prior authorization turnaround times for Anthem-licensed commercial plans are governed by state insurance regulations, which vary materially across states. For Medicare Advantage, Medicaid managed care, CHIP, and QHP plans, Anthem is impacted by CMS-0057-F, which mandates 72-hour standard and 24-hour expedited PA decision timeframes on a phased compliance timeline. Appeals for standard medical PAs route through the Anthem operating company's documented appeals process, with peer-to-peer reviews available.

Frequently asked questions

Which Anthem portal should I use for allergy & immunology medical prior authorizations?

For medical benefit prior authorizations, including many allergy & immunology services, Anthem-licensed plans direct submissions through Availity Essentials. This multi-payer provider workspace handles PA initiation, member benefit lookups, and document uploads.

Are biologics for asthma and other allergic conditions always subject to PA with Anthem?

Yes, high-cost biologics used in allergy & immunology, such as those for asthma, are typically subject to prior authorization by Anthem-licensed plans. These often require adherence to specific clinical criteria and may involve step therapy protocols.

How do I access Anthem's clinical criteria for IVIG or SCIG therapies?

Anthem's medical policies and clinical utilization management guidelines for IVIG/SCIG therapies are published on their provider sites, accessible through Availity. It's crucial to consult the specific policy number, plan-state context, and effective date, as criteria can vary.

Does Anthem support electronic prior authorization (ePA) for allergy & immunology pharmacy drugs?

Yes, for pharmacy benefit prior authorizations related to allergy & immunology drugs, Anthem's in-house PBM, CarelonRx, supports ePA through partners like CoverMyMeds and Surescripts for prescriber-initiated workflows.

What are common reasons for denial of allergy & immunology prior authorizations by Anthem?

Common denial reasons include medical necessity not met, insufficient documentation, failure to complete step therapy, site-of-service mismatch for infusions, or the service not being covered under the specific state-plan benefit grid. Denials are communicated via X12 277/835 transactions and Availity.